Tag Archives: about

KHN’s ‘What The Health?’: All About ‘Medicare for All’

Can’t see the audio player? Click here to listen on SoundCloud. We’re doing something a little different this holiday week. Because “Medicare for All” is so much in the news, we’re rerunning an earlier explainer episode. Special Reports But first, KHN’s “What the Health?” host Julie Rovner talks with KHN correspondent Shefali Luthra about how health… Read More »

Bluebird CEO defends $1.8 million gene therapy price — ‘It’s really thinking about it differently’

Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no… Read More »